Medullary Thyroid Cancer
📧 Sign up to get email alerts when something new happens for Medullary Thyroid Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cultural Adaptation of an Educational Tool in Medullary Thyroid Cancer
This clinical trial update reports that a study to culturally adapt an educational tool for patients with medullary thyroid cancer is curren…
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: Prospective Study Evaluating the Medullary Thyroid Cancer Management's Care Using PET F-DOPA in Patients With a High Level of Postoperative Residual Thyrocalcitonin [NA]
The document reports the completion of a prospective study evaluating the use of PET F-DOPA imaging to guide management of medullary thyroid…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: QUILT-3.006 for Recurrent Medullary Thyroid Cancer [Phase 2]
Phase 2 trial QUILT-3.006 for recurrent medullary thyroid cancer has completed, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-01-30Clinical Trial Update: A Study of TY-1091 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial update for TY-1091 in patients with RET-altered solid tumors, including RET-altered non-small cell lung cancer an…
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Phase I/II Study of SY-5007, a RET Inhibitor, in Patients With RET-altered Advanced Solid Tumor [Phase 1, Phase 2]
Phase I/II clinical trial update for SY-5007, a RET inhibitor, in RET-altered advanced solid tumors including non-small cell lung cancer and…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-02-11Clinical Trial Update: Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer [Phase 2]
Phase 2 trial updating pembrolizumab for recurrent or metastatic medullary thyroid cancer has completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-01-22Clinical Trial Update: Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer [Phase 2]
Phase 2 adaptive TKI therapy trial in thyroid cancer was terminated; results posted previously.
-
CLINICAL_TRIALS trial_result · 2020-10-19Clinical Trial Update: Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors [Phase 1, Phase 2]
Clinical trial update for rovalpituzumab tesirine in DL3-expressing advanced solid tumors shows termination with results posted.
-
CLINICAL_TRIALS trial_result · 2019-11-18Clinical Trial Update: Phase II Trial of Sorafenib (Nexavar) in Patients With Advanced Thyroid Cancer [Phase 2]
Phase II trial of Sorafenib (Nexavar) in advanced thyroid cancers completed; results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-08-01Clinical Trial Update: Evaluating the Safety and Efficacy of Oral Lenvatinib in Medullary and Iodine-131 Refractory, Unresectable Differentiated Thyroid Cancers, Stratified by Histology [Phase 2]
Phase 2 trial evaluating safety and efficacy of oral lenvatinib in medullary and iodine-131 refractory, unresectable differentiated thyroid …
-
CLINICAL_TRIALS trial_result · 2016-12-12Clinical Trial Update: An Initial Study of Lithium in Patients With Medullary Thyroid Cancer [Phase 2]
Phase 2 clinical trial evaluating lithium in patients with medullary thyroid cancer was terminated; results posted in 2016.
-
CLINICAL_TRIALS trial_result · 2016-09-07Clinical Trial Update: Radiolabeled Molecules for Medullary Thyroid Cancer [Phase 4]
Phase 4 clinical trial update evaluating radiolabeled molecules for medullary thyroid cancer, sponsored by Instituto Nacional de Cancer in B…
-
CLINICAL_TRIALS trial_result · 2014-11-24Clinical Trial Update: Study to Determine if Contacting Patients With MTC More Frequently Results in Earlier Detection and Treatment of Signs and Symptoms of AEs and Thus a Decrease in the Percentage of Time Patients Experience AEs During First 12 Months on Vandetanib Treatment [Phase 3]
A Phase 3 trial evaluated whether more frequent contact with patients improves early detection and management of adverse events during Vande…
-
CLINICAL_TRIALS approval · 2013-01-16Clinical Trial Update: Expanded Access of Cabozantinib in Medullary Thyroid Cancer
The document reports expanded access for cabozantinib in medullary thyroid cancer and indicates marketing approval status.